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Immunity against blood stage Plasmodium falciparum  malaria  can be passively 
transferred with immune gamma globulin (1), and protective antibodies appear 
to act against the merozoite form of the parasite (2).  For vaccine development, 
therefore,  it  is  important  to  identify and  characterize  the  surface antigens  of 
merozoites  against  which  protective antibodies  may be directed.  We have re- 
ported the  identification  of a  195,000  mol wt protein antigen  of P. falciparum 
that  is  synthesized  in  schizonts  and  processed  through  a  series  of  discrete 
fragments  during  the  last  few hours  of the parasite's  intraerythrocytic  growth 
cycle (3). The major processing product detected after merozoite differentiation 
was an 83,000 mol wt fragment,  and it was suggested that this fragment of the 
•95,000  tool  wt precursor  may be expressed  on  the  merozoite  surface.  More 
recently, we have demonstrated a serological cross-reaction between the 195,000 
mol wt P. falciparum antigen and a  230,000 mol wt antigen  ofP. yoelii that can 
be  used  in  purified  form  to  immunize  mice  against P.  yoelii malaria  (4).  The 
195,000 tool wt P. falciparum protein, and its form on the merozoite surface, are 
therefore of considerable interest for malaria vaccine development. 
We have now analyzed the surface antigens  of naturally released merozoites 
harvested from P. falciparum cultures.  The results show that the 83,000 mol wt 
fragment  of the  195,000  mol  wt  precursor  is  expressed  on  the  surface  of 
merozoites, and that it is a major merozoite surface antigen immunoprecipitated 
by human immune serum. 
Materials and Methods 
Media and  Reagents.  RPMI  1640  tissue-culture  medium  was  obtained  from  Flow 
Laboratories Ltd., Ayrshire,  Scotland  and  methionine-free RPMI  1640 was purchased 
from Gibco Laboratories, Grand Island,  NY. o-Sorbitol and D-glucose were supplied  by 
BDH Ltd.,  Poole,  England.  Sodium  deoxycholate,  trypsin  (type XI),  lactoperoxidase, 
phenylmethyl sulfonyl fluoride (PMSF) 1, and tosyl-L-lysine chloromethyi ketone (TLCK) 
were purchased from Sigma Chemical Co., St. Louis, MO. The radiolabeled compounds 
L-[~r'S]metbionine (sp act,  800-1,200  Ci/mmol)  and  [~z~I]NaI (17  Ci/mg  iodine)  were 
obtained from Amersham International Ltd., Amersham,  England. 
The  mouse-mouse  IgG1  monoclonal  antibody  89.1  was  obtained  in  serum  from 
BALB/c mice carrying the hybridoma WIC 89.1  as ascites tumors.  The production of 
~Abbreviations used in  this paper:  PMSF, phenylmethyl sulfonyl fluoride; SDS-PAGE, sodium 
dodecyl sulfate-polyacrylamide  gel electrophoresis; TLCK, tosyl-L-lysine  chloromethyl ketone. 
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hybridoma WIC 89.1  and the characterization of antibody 89.1  have been described in 
detail elsewhere (3). Antibody 89.1 is specific for a  195,000 mol wt P. falciparum schizont 
protein, and also for 153,000, 150,000,  110,000, and 83,000 tool wt processing fragments 
derived from the 195,000 tool wt precursor. 
A  pool  of human  serum  was  made  from samples of serum  from  14  P. falciparum- 
immune  donors  resident  in  The  Gambia.  The  samples  were  supplied  by  Dr.  B.  M. 
Greenwood, Medical Research Council Laboratories, The Gambia. 
Collection of  P. falciparum Merozoites.  The West African Wellcome strain of P. falciparum 
was cultured  in plastic tissue-culture flasks as previously described (3).  In these experi- 
ments, a 5% hematocrit was used and the flasks, each containing 24 ml of cell suspension, 
were shaken at 50 rpm in an orbital incubator (model Mk X; L. H. Engineering Co. Ltd., 
Bells Hill, Stoke Poges, Buckinghamshire, England). The suspension cultures were cen- 
trifuged  each  day  to  enable  the  supernatant  medium  (RPMI  1640  with  10%  human 
serum) to be changed. Parasite development was synchronized using sorbitol (5). 
For merozoite collection, cultures at 20% parasitemia were sorbitol treated to give a 
parasitemia of 18%  ring-forms. After 3 h  further incubation,  the cells were washed in 
digestion buffer (10 mM Tris-HCi, pH 7.6,  150 mM NaCI, 10 mM glucose, 1 mM CaCI~, 
1 mM MgCI~) and resuspended at  10% hematocrit in digestion buffer to which trypsin 
was added to 1 mg]ml (6). After 60 rain at 37°C the cells were washed in culture medium 
and resuspended at 5% hematocrit. The cultures were then returned  to the incubator. 
Next morning the medium was changed as usual; 32 h after the sorbitol treatment, when 
schizont maturation and merozoite release was occurring, the cultures were transferred 
to sterile 50-ml centrifuge tubes and centrifuged at 550 g for 5 min. The supernatant was 
replaced with 20 ml per tube of fresh medium. The cells were replaced in new flasks that 
were then gassed, sealed, and returned to the incubator. After 60 min the cultures were 
centrifuged at 550 g for 5 rain, then the supernatants were centrifuged at 3,000 g for 10 
min. The pelleted merozoites were then processed as required. Each flask yielded ---5 × 
10 s merozoites, assessed by counting in a bacterial cell-counting chamber under phase- 
contrast optics. 
[35S]Methionine  Biosynthetic Labeling.  Two 24-mi cultures  were treated with sorbitol 
and then trypsin as described above. At 27 h  after the sorbitol treatment, the cultures 
were pulse  labeled with  60  ~Ci/ml [35S]methionine  in  methionine-free medium for 60 
min as described previously (3).  After the  labeling period,  the  cells in  one flask were 
washed in digestion buffer and frozen as a pellet at -80°C. The cells in the other flask 
were washed in culture medium, then made to 24 ml with culture medium, and returned 
to the incubator. 5 h later, released merozoites were collected as described above, washed 
in 1 ml digestion buffer, and pelleted by centrifugation at 10,000 g for 1 min. The pellet 
was frozen at -80°C. 
Lactoperoxidase-catalyzed Iodination.  The merozoites collected from one 24-ml culture 
(5 x  10 a) were resuspended in 10 ml of labeling buffer (80 mM NaCI, 5 mM KCI, 1 mM 
MgSO4,  10 mM glucose, 20 mM Na2HPO4, 2 mM NaH~PO4, pH 7.4) and centrifuged at 
3,000 g for 10 mins. The merozoites were resuspended in 0.1  ml of labeling buffer and 
surface labeled with [125I] by the lactoperoxidase method as described by Johnson et al. 
(7). The labeled merozoites were washed twice in labeling buffer and the merozoite pellet 
was frozen at -80°C. 
Cell Solubilization, Immunoprecipitation,  and Electrophoresis.  The frozen cell pellets were 
thawed into buffer containing 50 mM Tris-HCl, pH 8.0, 5 mM EDTA, 5 mM EGTA, 5 
mM iodoacetamide, 1 mM PMSF, 0.1 mM TLCK, and 0.5% (wt]vol) sodium deoxycholate, 
and extracted on ice for  10  min.  Insoluble material was removed by centrifugation at 
100,000 g for 45  rain at 4°C.  Immunoprecipitations, sodium dodecyl sulfate-polyacryl- 
amide gel electrophoresis (SDS-PAGE) using  7.5%  slab gels,  and  detection  of labeled 
bands  by fluorography were performed as described previously (3).  Molecular weight 
markers were human spectrin heterodimer (240,000 and 220,000 mol wt), ~-galactosidase 
(116,000 mol wt), phosphorylase b (93,000 mol wt), bovine serum albumin (68,000 mol 
wt), and aldolase (39,000 mol wt). 
Western Transfer Analysis.  Samples of solubilized P. falciparum schizont and merozoite FREEMAN  AND  HOLDER  1649 
proteins were subjected to SDS-PAGE, then transferred  electrophoretically to a  nitrocel- 
lulose sheet (8). The sheet was washed, probed with monoclonal antibody 89.1, developed 
with [~25I]-labeled rabbit anti-mouse IgG, and autoradiographed as described elsewhere 
(4). 
Results 
[3~S]Methionine-labeled Schizont and Merozoite Proteins.  Most  of the  proteins 
synthesized in schizonts (Fig.  1, lane  1) were retained in merozoites released 5 h 
after the labeling period (lane 5), with some notable exceptions. Major schizont 
proteins of 235,000,  205,000,  195,000,  185,000,  153,000, and 78,000  mol wt 
were absent from merozoites, and must have been either excluded, degraded, 
or modified during merozoite formation. 
[35S]Methionine-labeled  Schizont and  Merozoite Antigens  Recognized by  Immune 
Serum.  Many proteins synthesized in schizonts were not immunoprecipitated by 
human  immune  serum  (Fig.  1,  lane  2).  Thus,  schizont  proteins  of 230,000, 
120,000,  95,000,  93,000,  78,000,  75,000,  55,000,  50,000, and 45,000  mol wt 
do not appear to induce significant antibody titers in immune individuals. Neither 
were these  proteins precipitated  from extracts  of free  merozoites by  immune 
serum  (lane  6).  In  merozoites,  the  range  of antigens  synthesized  5  h  before 
release and recognized by immune serum was limited to polypeptides of 150,000, 
140,000,  108,000, 83,000, and 41,000 mol wt. Minor bands at 88,000, 65,000, 
39,000, and 33,000 mol wt were also detected. 
[~SS]Methionine-labeled Schizont and Merozoite Antigens Recognized by Monoclonal 
Antibody 89.1.  During the 60-min pulse labeling of schizonts with [~SS]methio- 
nine, the  195,000 mol wt protein immunoprecipitated by monocional antibody 
89.1  was  synthesized  abundantly  and  only partially  processed  into  its specific 
fragments (Fig.  1, lane 3). The bulk of the protein was precipitated in nonpro- 
cessed  form  and  as  the  153,000  mol  wt  fragment.  However,  in  merozoites 
FIGURE  1.  SDS-PAGE analysis of [ssS]methionine-labeled proteins synthesized in schizonts 
(lanes  1-4) and retained in merozoites released 5  h after pulse labeling (lanes 5-8).  Lanes  1 
and 5 show total labeled proteins. Lanes 2 and 6 show proteins immunoprecipitated by human 
immune serum.  Lanes  3  and  7  show proteins  immunoprecipitated  by monoclonal antibody 
89.1.  Lanes  4  and  8  are  control  immunoprecipitations  using  normal  mouse  serum.  The 
positions of the molecular weight markers and the  195,000 and 83,000 tool wt P. falciparum 
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released after  a  5-h  chase  with  cold methionine,  the  only labeled polypeptide 
precipitated by antibody 89.1 was the 83,000 mol wt fragment (lane 7). 
Western Transfer Analysis of Schizont and Merozoite Antigens Recognized by Monoclo- 
hal Antibody 89. I.  Pulse labeling with [~SS]methionine had been performed 5 h 
before merozoite release,  and  it remained  possible that  some  195,000  tool wt 
protein,  synthesized after  the pulse-labeling  period,  may have  been associated 
with merozoites, but not detected amongst the labeled polypeptides immunopre- 
cipitated  by  antibody  89.1.  Western  transfer  analysis  was  used  to  check  this 
possibility. Total unlabeled schizont and merozoite proteins were transferred to 
nitrocellulose and probed with antibody 89.1.  In schizonts, the  195,000 mol wt 
precursor and its processing fragments were detected, whereas in merozoites the 
only polypeptide present  recognized by antibody  89.1  was the  83,000  mol  wt 
fragment (Fig. 2). 
[125I]Surface-labeled Merozoite Proteins.  The SDS-PAGE profile of the surface 
proteins  of P. falciparum  merozoites  labeled by lactoperoxidase-catalyzed  iodi- 
nation is shown in Fig. 3, lane 1. The molecular weights of the labeled merozoite 
surface proteins were estimated to be 160,000,  105,000, 83,000, 73,000, 70,000, 
65,000,  48,000,  42,000,  41,000,  38,500,  and  37,000 mol wt. The 83,000  mol 
wt polypeptide was a major labeled species. 
[1251]Surface-labeled Merozoite Antigens Recognized by Immune Serum and Monoclo- 
hal Antibody 89.1.  Human immune serum precipitated surface-labeled polypep- 
tides of 88,000,  83,000,  65,000,  48,000,  42,000,  41,000,  and  35,000  mol  wt 
(Fig. 3, lane 2).  Of these seven surface antigens,  the 83,000 and 42,000 mol wt 
species were apparently  the  most abundant.  Monoclonal antibody  89.1  immu- 
noprecipitated only the 83,000 tool wt species (lane 3). 
Discussion 
The  method  we have  used for obtaining  naturally  released merozoites from 
P. falciparum  cultures derives from the recent demonstration  by Breuer,  Gins- 
FIGURE 2.  Autoradiograph of a Western blot of unlabeled schizont (lane 1) and merozoite 
(lane 2) proteins, probed with monoclonal antibody 89.1 and developed with 1~5I-labeled 
rabbit anti-mouse IgG. The positions of the  195,000 and 83,000 mol wt polypeptides are 
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FIGURE 3.  SDS-PAGE  analysis of total [1~5I] surface-labeled  P.falciparum merozoite  proteins 
(lane 1),  and  those immunoprecipitated by human immune serum (lane 2),  monoclonal 
antibody 89.1 (lane 3), and normal mouse serum (lane 4). Positions of the molecular weight 
markers are indicated. 
burg, and Cabantchik (6) that trypsin treatment oferythrocytes does not interfere 
with intracellular parasite development or merozoite release, while it does render 
erythrocytes refractory to invasion.  Trypsin treatment of synchronized cultures 
enables released merozoites to be harvested  with  much  higher  yields than  has 
been  otherwise  possible  (9-11).  Using  this  procedure,  the  culture  medium  is 
changed four times between the trypsin treatment and merozoite release, so the 
released  merozoites  are  not  exposed to  trypsin  digestion.  The  merozoites  ob- 
tained are mostly intact and free from contamination  with schizonts and eryth- 
rocytes, as assessed by light and electron microscopy (not shown). 
The biosynthesis of high molecular weight proteins in schizonts of  P. falciparum 
has been  noted by several groups  (3,  12,  13), and  we have used a  monoclonal 
antibody to demonstrate  that  a  195,000  mol  wt schizont protein  is specifically 
processed  into  smaller  fragments  as  schizonts  mature  (3).  The  results  of the 
pulse-chase labeling experiment in the present study indicate that several other 
schizont proteins may be similarly processed as merozoites develop. 
Only  five  major  [35S]methionine-labeled  polypeptides  were  immunoprecipi- 
tated from merozoite extracts by human  immune serum.  One of these was the 
83,000 mol wt fragment recognized by monoclonal antibody 89.1  and derived 
from  the  195,000  mol  wt precursor  protein  synthesized  in  schizonts.  None of 
the intermediate  fragments  (3) was associated with merozoites, and thus it can 
be concluded that the 83,000 tool wt antigen  is an end product of processing of 
the  195,000  mol  wt  precursor,  and  that  it  is  a  major  component  of  free 
merozoites. This conclusion is supported by Western transfer analysis ofschizont 
and merozoite antigens. 
The  profile of iactoperoxidase-iodinated  merozoite proteins  of P. falciparum 
was similar  to that  found for merozoite surface proteins of P.  knowlesi  (7),  and 
the  results  of  Miller  et  al.  (14)  indicate  extensive  serological  cross-reaction 
between the  merozoite  surface antigens  of these  two malaria  parasite  species. 
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proteins, including proteins of 150,000 and  105,000 mol wt (14).  However, in 
the present study, human immune serum did not immunoprecipitate the 160,000 
or the  105,000 mol wt P. falciparum merozoite surface proteins; an 88,000 mol 
wt  species  was  the  largest  surface  antigen  precipitated.  The  83,000  mol  wt 
polypeptide recognized by antibody 89.1 was clearly one of the major merozoite 
surface antigens precipitated by human immune serum. 
Further study will be required in order to elucidate the function of the 83,000 
mol  wt  polypeptide,  the  mechanism  of its  processing  and  attachment  at  the 
merozoite  surface,  and  its  role  in  protective  immunity  against  P. falciparum 
malaria.  It has been established, however, that it cross-reacts serologically with a 
known  protective antigen  of a  rodent  malaria  parasite,  P. yoelii (4).  Thus,  the 
immunochemical characteristics of the 83,000 mol wt merozoite surface antigen 
indicate that it may be an important  candidate for use in immunization  against 
the blood stage of P. falciparum malaria. 
Summary 
A  technique  was  developed  for  obtaining  high  yields  of naturally  released 
Plasmodiumfalciparum merozoites from synchronous cultures of parasitized eryth- 
rocytes. The cultured erythrocytes were treated with trypsin to prevent reinva- 
sion  (6),  and  the  released  merozoites  that  accumulated  extracellularly  were 
harvested by differential centrifugation.  The total biosynthetically labeled pro- 
teins  of schizonts  and  merozoites,  and  those  immunoprecipitated  by  human 
immune  serum  were  analyzed  and  compared.  The  surface  antigens  of  free 
merozoites, labeled by lactoperoxidase-catalyzed iodination, were also described. 
A  monoclonal  antibody,  specific  for  a  195,000  mol  wt  schizont  protein,  and 
processing fragments derived from it (3) were used in immunoprecipitation and 
Western  transfer  analyses to determine which of the processing fragments are 
associated  with  merozoites  and  which  of them  are  located  on  the  merozoite 
surface. It was found that processing of the  195,000 mol wt precursor down to 
an 83,000 mol wt fragment is complete in free merozoites, and that this fragment 
is expressed as one of the major surface antigens of P. falciparum merozoites. 
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manuscript preparation. 
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